News Conference News SCAI 2023 Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis L.A. McKeown May 30, 2023
News Daily News Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups Michael O'Riordan May 09, 2023
News Daily News New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF L.A. McKeown April 19, 2023
News Daily News Inactivity Pandemic Poised to Undo CVD Prevention Advances Michael O'Riordan April 11, 2023
News Conference News ACC 2023 Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR Michael O'Riordan March 13, 2023
News Conference News ACC 2023 Studies Support (Careful) Return to Sport for Athletes With Genetic Conditions Michael O'Riordan March 07, 2023
News Conference News ACC 2023 Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes Michael O'Riordan March 04, 2023
News Daily News Don’t Just Prescribe a Statin—Measure and Control LDL, Say NLA, ASPC Michael O'Riordan March 01, 2023
News Daily News For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI Michael O'Riordan February 23, 2023
News Daily News Longer-Term ASCVD Risk Assessment Best for Younger Patients Michael O'Riordan February 16, 2023
News Daily News Periprocedural Adverse Events and Late Mortality: More Nuance From EXCEL Michael O'Riordan February 15, 2023
News Daily News Risk of Sports-Related Sudden Cardiac Arrest Low in Older Adults Michael O'Riordan February 09, 2023
News Daily News Obesity and CVD: New Review Highlights Where Tools and Meds Fall Short Shelley Wood January 31, 2023
News Daily News For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread Michael O'Riordan January 30, 2023
News Conference News STS 2023 Large Medicare Analysis Reopens Debate Over Multivessel Revascularization Yael L. Maxwell January 24, 2023
News Daily News UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy Michael O'Riordan January 20, 2023
News Daily News CT Angiography Is Increasing in England, but Downstream Tests Are Not Michael O'Riordan January 12, 2023
News Features Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends Michael O'Riordan January 06, 2023